Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 02, 2023

BUY
$0.45 - $11.67 $45 - $1,167
100 Added 156.25%
164 $0
Q2 2022

Aug 03, 2022

SELL
$0.81 - $1.44 $810 - $1,440
-1,000 Reduced 93.98%
64 $0
Q1 2022

May 02, 2022

SELL
$1.3 - $4.19 $217 - $699
-167 Reduced 13.57%
1,064 $1,000
Q4 2021

Feb 23, 2022

BUY
$3.81 - $6.17 $4,690 - $7,595
1,231 New
1,231 $4,000

About Talis Biomedical Corp


  • Ticker TLIS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 26,619,200
  • Market Cap $45.8M
  • Description
  • Talis Biomedical Corporation operates as a molecular diagnostic company. The company is developing the Talis One system to address limitations of existing point-of-care diagnostic testing technologies for infectious diseases. It also offers Talis One COVID-19 Test System, which focuses on detection of SARS-CoV-2, the virus that causes COVID-19. ...
More about TLIS
Track This Portfolio

Track Simplex Trading, LLC Portfolio

Follow Simplex Trading, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Simplex Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Simplex Trading, LLC with notifications on news.